Advertisement
Screener

GENELUX CORPORATION (GNLX) Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit

1.7 / 5 stars · 8/23 Roast Me

GENELUX CORPORATION Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit

GENELUX CORPORATION (GNLX) reported Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit of $24.75 per share for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-06.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit · last filed 2025-05-06

  • GENELUX CORPORATION share-based payment arrangement, option, exercise price range, upper range limit for the quarter ending 2025-03-31 was $24.75.
  • GENELUX CORPORATION share-based payment arrangement, option, exercise price range, upper range limit for fiscal 2024 was $24.75.
Period endShare-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit 3 monthShare-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit 6 monthShare-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit 9 monthShare-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit 12 month
2025-03-31$24.75
10-Q · filed 2025-05-06
2024-12-31$24.75
10-K · filed 2025-03-28
2024-09-30$24.75
10-Q · filed 2024-11-14
2024-06-30$24.75
10-Q · filed 2024-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
BICYCLE THERAPEUTICS PLC (BCYC)$0.112B-1.56
Equillium, Inc. (EQ)United States$0.109B-11.27
Quantum Cyber N.V. (QUCY)$0.113B
Immuneering Corp (IMRX)United States$0.113B-12.51
Biomea Fusion, Inc. (BMEA)United States$0.107B-3.30
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
ProMIS Neurosciences Inc. (PMN)$0.102B
OnKure Therapeutics, Inc. (OKUR)United States$0.119B-3.13
Coya Therapeutics, Inc. (COYA)United States$0.121B-6.35
CUMBERLAND PHARMACEUTICALS INC (CPIX)United States$0.121B-8.95